Dabrafenib in pediatric patients with BRAF V600–positive high-grade glioma (HGG).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Darren R Hargrave, Lucas Moreno, Alberto Broniscer, Eric Bouffet, Isabelle Aerts, Nicolas Andre, Wei-Ping Violet Shen, Anne-Isabelle Bertozzi-Salamon, Kenneth J. Cohen, Ira J. Dunkel, Mark W. Kieran, Andrej Lissat, Mark W. Russo, Kohinoor Dasgupta, Lillian Tseng, Bijoyesh Mookerjee, Birgit Geoerger
Institutions: Great Ormond Street Hospital, Hospital Infantil Universitario Niño Jesús, St. Jude Children's Research Hospital, University of Toronto, Hospital for Sick Children, Université Paris Sciences et Lettres, Institut Curie, Hôpital de la Timone, Children's Hospital of Orange County, Centre Hospitalier Universitaire de Toulouse, Hôpital des Enfants, Johns Hopkins Hospital, Memorial Sloan Kettering Cancer Center, Harvard University, Charité - Universitätsmedizin Berlin, Novartis (India), Institut Gustave Roussy
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890058595